A study comparing P2Y12 inhibitors in Australian patients undergoing PCI has found that prasugrel in combination with aspirin was associated with better two-year outcomes compared to ticagrelor and clopidogrel. Prasugrel had significantly lower rates of the composite outcome of death, myocardial infarction and stroke at one and two years after PCI compared to other P2Y12 ...
Ischaemic heart disease
Antiplatelets compared in PCI: one stands out in Australian study
By Michael Woodhead
1 Sep 2020